Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P MacCarthy

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Annals of Internal Medicine|August 1, 1987
Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazideB Massie, E P MacCarthy, K B Ramanathan, et al.
Archives of Internal Medicine|December 1, 1989
Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trialJ D Wallin, E Fletcher, C V Ram, et al.
Heart and Vessels|September 20, 2020
Pre-procedural pacing bias among transcatheter aortic valves with higher post-procedure pacing rates: evidence from the UK TAVI RegistryR Hilling-Smith, J Smethurst, J Cockburn, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
The value, qualification, and regulatory use of surrogate end points in drug developmentC D Lathia, D Amakye, W Dai, et al.
American Journal of Hypertension|March 1, 1992
A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertensionH R Black, A J Lewin, G H Stein, et al.
British Journal of Clinical Pharmacology|October 1, 1989
Lisinopril dose-response relationship in essential hypertensionH J Gomez, V J Cirillo, J A Sromovsky, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Annals of Internal Medicine|August 1, 1987
Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazideB Massie, E P MacCarthy, K B Ramanathan, et al.
Archives of Internal Medicine|December 1, 1989
Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trialJ D Wallin, E Fletcher, C V Ram, et al.
Heart and Vessels|September 20, 2020
Pre-procedural pacing bias among transcatheter aortic valves with higher post-procedure pacing rates: evidence from the UK TAVI RegistryR Hilling-Smith, J Smethurst, J Cockburn, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
The value, qualification, and regulatory use of surrogate end points in drug developmentC D Lathia, D Amakye, W Dai, et al.
American Journal of Hypertension|March 1, 1992
A comparison of the safety of therapeutically equivalent doses of isradipine and diltiazem for treatment of essential hypertensionH R Black, A J Lewin, G H Stein, et al.
British Journal of Clinical Pharmacology|October 1, 1989
Lisinopril dose-response relationship in essential hypertensionH J Gomez, V J Cirillo, J A Sromovsky, et al.
Pageof 7